Ignite Creation Date:
2025-12-24 @ 10:12 PM
Ignite Modification Date:
2026-06-29 @ 2:34 AM
Study NCT ID:
NCT05346835
Status:
AVAILABLE
Last Update Posted:
2025-08-27
First Post:
2022-03-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple Myeloma
Sponsor:
Janssen Scientific Affairs, LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Multiple Myeloma | View |
Keywords: